Nomura Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Nomura Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.1M	Sell	1,124,772 -1,213,830	-52%	-$40.4M	0.04%	232
2026 Q1	$70.4M	Buy	+2,338,602	New	+$75.2M	0.19%	85
2025 Q4	–	Sell	-858,728	Closed	-$21.2M	–	2161
2025 Q3	$17.3M	Buy	858,728 +724,126	+538%	+$12.7M	0.03%	350
2025 Q2	$2.26M	Buy	+134,602	New	+$2.17M	﹤0.01%	805
2024 Q1	–	Sell	-15,000	Closed	-$157K	–	2017
2023 Q4	$157K	Buy	+15,000	New	+$140K	﹤0.01%	1615
2023 Q3	–	Sell	-21,789	Closed	-$203K	–	1635
2023 Q2	$164K	Buy	+21,789	New	+$177K	﹤0.01%	1180
2023 Q1	–	Sell	-20,685	Closed	-$189K	–	1714
2022 Q4	$189K	Sell	20,685 -79,675	-79%	-$695K	﹤0.01%	1116
2022 Q3	$810K	Sell	100,360 -174,640	-64%	-$1.54M	﹤0.01%	1001
2022 Q2	$2.19M	Buy	275,000 +138,553	+102%	+$1.21M	0.01%	780
2022 Q1	$1.28M	Buy	136,447 +60,780	+80%	+$507K	﹤0.01%	1019
2021 Q4	$606K	Buy	75,667 +1,123	+2%	+$10.1K	﹤0.01%	1398
2021 Q3	$743K	Sell	74,544 -14,418	-16%	-$135K	﹤0.01%	1239
2021 Q2	$892K	Sell	88,962 -106,185	-54%	-$1.12M	﹤0.01%	1118
2021 Q1	$2.21M	Sell	195,147 -28,283	-13%	-$324K	0.01%	822
2020 Q4	$2.15M	Sell	223,430 -100,073	-31%	-$959K	﹤0.01%	827
2020 Q3	$2.92M	Buy	323,503 +125,374	+63%	+$1.33M	0.01%	579
2020 Q2	$2.43M	Sell	198,129 -164,890	-45%	-$1.86M	0.01%	524
2020 Q1	$3.22M	Buy	363,019 +291,849	+410%	+$2.99M	0.01%	388
2019 Q4	$697K	Sell	71,170 -346,641	-83%	-$3.09M	﹤0.01%	860
2019 Q3	$2.83M	Buy	417,811 +21,164	+5%	+$162K	0.01%	583
2019 Q2	$3.7M	Buy	396,647 +323,027	+439%	+$3.9M	0.02%	559
2019 Q1	$1.16M	Sell	73,620 -39,188	-35%	-$691K	﹤0.01%	795
2018 Q4	$1.83M	Sell	112,808 -6,009	-5%	-$123K	0.01%	719
2018 Q3	$2.55M	Buy	118,817 +73,244	+161%	+$1.7M	0.01%	668
2018 Q2	$864K	Sell	45,573 -4,274	-9%	-$87.2K	﹤0.01%	898
2018 Q1	$852K	Sell	49,847 -26,565	-35%	-$519K	﹤0.01%	1095
2017 Q4	$1.45M	Buy	76,412 +23,534	+45%	+$354K	﹤0.01%	988
2017 Q3	$930K	Buy	52,878 +50,121	+1,818%	+$1.13M	﹤0.01%	1074
2017 Q2	$92K	Sell	2,757 -33,471	-92%	-$1.04M	﹤0.01%	1424
2017 Q1	$1.16M	Sell	36,228 -137,297	-79%	-$4.69M	﹤0.01%	760
2016 Q4	$6.29M	Sell	173,525 -657,566	-79%	-$26.3M	0.02%	492
2016 Q3	$38.3M	Buy	831,091 +42,280	+5%	+$2.21M	0.11%	109
2016 Q2	$39.6M	Buy	+788,811	New	+$42M	0.13%	85
2016 Q1	–	Sell	-80,000	Closed	-$5.26M	–	1979
2015 Q4	$5.26M	Buy	80,000 +60,457	+309%	+$3.74M	0.01%	395
2015 Q3	$987K	Sell	19,543 -359,872	-95%	-$23.3M	﹤0.01%	755
2015 Q2	$19.2M	Buy	+379,415	New	+$23.4M	0.05%	157
2015 Q1	–	Sell	-1,040,409	Closed	-$52.5M	–	2249
2014 Q4	$52.5M	Sell	1,040,409 -462,712	-31%	-$25.8M	0.14%	96
2014 Q3	$75.9M	Buy	1,503,121 +1,059,729	+239%	+$56.1M	0.21%	86
2014 Q2	$23.2M	Sell	443,392 -7,589	-2%	-$388K	0.01%	269
2014 Q1	$23.6M	Buy	450,981 +433,234	+2,441%	+$20M	0.01%	243
2013 Q4	$711K	Sell	17,747 -57,437	-76%	-$2.26M	﹤0.01%	1125
2013 Q3	$2.84M	Buy	75,184 +69,297	+1,177%	+$2.7M	0.02%	694
2013 Q2	$230K	Buy	+5,887	New	+$229K	﹤0.01%	1762

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Nomura Holdings's TEVA Position: Q2 2026 in Review

Nomura Holdings reduced its Teva Pharmaceuticals (TEVA) stake by 52% in Q2 2026, selling an estimated $40.4M and leaving 1,124,772 shares worth $38.1M. The position accounts for 0.04% of the portfolio, ranked #232.

Nomura Holdings first reported a position in TEVA in Q2 2013 and has held it in 43 quarters since. The position peaked at $75.9M in Q3 2014. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Nomura Holdings held 1,124,772 shares of Teva Pharmaceuticals worth $38.1M as of Q2 2026.
Nomura Holdings sold 1,213,830 Teva Pharmaceuticals shares in Q2 2026, an estimated $40.4M.
Teva Pharmaceuticals made up 0.04% of Nomura Holdings's portfolio in Q2 2026, its #232 holding.
Nomura Holdings first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 43 quarters since.
Nomura Holdings's Teva Pharmaceuticals position peaked at $75.9M in Q3 2014.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.